e-learning
resources
Paris 2018
Wednesday, 19.09.2018
The importance of the pulmonary function test in different clinical settings
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The frequent exacerbator phenotype in bronchiectasis: predictors and particularities
A. Ben Saad (Monastir , Tunisia), S. Cheikh Mhamed (Monastir , Tunisia), G. Trigui (Monastir , Tunisia), N. Fahem (Monastir , Tunisia), A. Migaou (Monastir , Tunisia), S. Joobeur (Monastir , Tunisia), N. Rouatbi (Monastir , Tunisia)
Source:
International Congress 2018 – The importance of the pulmonary function test in different clinical settings
Session:
The importance of the pulmonary function test in different clinical settings
Session type:
Poster Discussion
Number:
5292
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Ben Saad (Monastir , Tunisia), S. Cheikh Mhamed (Monastir , Tunisia), G. Trigui (Monastir , Tunisia), N. Fahem (Monastir , Tunisia), A. Migaou (Monastir , Tunisia), S. Joobeur (Monastir , Tunisia), N. Rouatbi (Monastir , Tunisia). The frequent exacerbator phenotype in bronchiectasis: predictors and particularities. 5292
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
The frequent exacerbator phenotype in asthma: a clinical characterization
Source: Virtual Congress 2020 – Phenotypes of obstructive diseases
Year: 2020
Exacerbation phenotypes of frequent versus non-frequent exacerbators among severe asthma patients
Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases
Year: 2019
Comparison of small airways disease measures between frequent and infrequent COPD exacerbators
Source: International Congress 2019 – Respiratory function assessment in disease
Year: 2019
Are comorbidities related to frequent severe exacerbations of COPD?
Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases
Year: 2019
Neutrophil-to-lymphocyte ratio predicts clinical outcome of severe acute exacerbation of COPD in frequent exacerbators
Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD
Year: 2021
Cardiovascular risk, subclinical atherosclerosis and markers of systemic inflammation in patients with COPD and frequent exacerbator phenotype
Source: International Congress 2016 – Monitoring comorbidities
Year: 2016
Identification of treatable traits in a severe asthma registry: prevalence and exacerbation predictors
Source: International Congress 2018 – Clinical determinants of asthma and biomarkers
Year: 2018
COPD and clinical phenotypes: Patients with concomitant pulmonary hypertension may be less likely to be frequent exacerbators
Source: International Congress 2014 – Clinical presentations
Year: 2014
Can we consider the "frequent exacerbator" a reliable COPD phenotype?
Source: International Congress 2015 – COPD: chronic disease and comorbidities
Year: 2015
Exacerbations in non- cystic fibrosis bronchiectasis (NCFB): is there a difference between self-reported events and those defined by the criteria in the literature?
Source: Virtual Congress 2021 – Bronchiectasis and pleural infection
Year: 2021
Cardiovascular comorbidities prevails in the early stages of COPD irrespective of predominant airway or emphysema phenotype
Source: Annual Congress 2013 –COPD treatment
Year: 2013
Exacerbations of COPD: relationship between presenting symptoms and outcome
Source: Eur Respir J 2004; 24: Suppl. 48, 63s
Year: 2004
The most frequent comorbidies in COPD and their inflence on the prognosis of the disease
Source: Annual Congress 2013 –COPD treatment and others
Year: 2013
Factors associated with frequent exacerbations in patients with severe asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 369s
Year: 2001
Frequent COPD exacerbators are not a stabile phenotype
Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases
Year: 2019
A high-risk airway mycobiome characterises frequent COPD exacerbators
Source: Virtual Congress 2020 – Airway infection: the microbiome and beyond
Year: 2020
Physiological impairments and exacerbation risk in COPD patients with less symptom and no frequent exacerbation history.
Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD
Year: 2021
Characteristics of "frequent exacerbators" in mild to moderate COPD patients.
Source: International Congress 2018 – COPD around the world
Year: 2018
Symptoms, functional parameters and exercise capacity in COPD patients with frequent and with infrequent exacerbations
Source: Eur Respir J 2003; 22: Suppl. 45, 406s
Year: 2003
Pulmonary rehabilitation in COPD exacerbator phenotype
Source: International Congress 2017 – Best abstracts in pulmonary rehabilitation in patients with chronic lung diseases
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept